Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of AK111 in Subjects With Active Ankylosing Spondylitis

NCT05467995 is registered in ClinicalTrials.gov with Akeso as lead sponsor.

NCT NCT05467995
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05467995 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of AK111 in Subjects With Active Ankylosing Spondylitis
Lead sponsor
Akeso
Phase
Phase 2
Overall status
Completed
Start date
June 2, 2021
Completion date
May 19, 2022
Enrollment
125 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

ankylosing spondylitis